Literature DB >> 3987558

Haemodynamic effects of short and long term administration of felodipine in spontaneously hypertensive rats.

M Nordlander.   

Abstract

Short term administration of felodipine to spontaneously hypertensive rats reduced mean arterial pressure, due to peripheral vasodilatation. This vasodilatation is generalised, since blood flow, determined by the microsphere technique, is maintained or increased in most vascular beds despite substantial mean arterial blood pressure reduction. The resistance and mean arterial blood pressure reduction after felodipine was counterbalanced by an increase in cardiac output. In short term therapy, cardiac output increased because of an increase in both heart rate and stroke volume. Following long term administration of felodipine cardiac output remained elevated owing to an increase in stroke volume. The lack of tachycardia during long term felodipine administration was shown to be due to a rapid resetting of the baroreflex control of heart rate. The marked increase in stroke volume after long term administration is suggested to be due to regression of left ventricular hypertrophy and structural rebuilding of the heart towards that characteristic of the well-trained athlete. Thus, the haemodynamic pattern induced by short term felodipine administration, and probably also other antihypertensive drugs, will become modified by neurogenic and structural adaptations upon prolonged administration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3987558     DOI: 10.2165/00003495-198500292-00018

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  22 in total

1.  Hemodynamic consequences of left ventricular hypertrophy in spontaneously hypertensive rats.

Authors:  M Hallbäck-Nordlander; E Noresson; P Thorén
Journal:  Am J Cardiol       Date:  1979-10-22       Impact factor: 2.778

2.  The fourth Volhard lecture: cardiovascular structural adaptation; its role in the initiation and maintenance of primary hypertension.

Authors:  B Folkow
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

3.  Cardiac hypertrophy in spontaneously hypertensive rats.

Authors:  S Sen; R C Tarazi; P A Khairallah; F M Bumpus
Journal:  Circ Res       Date:  1974-11       Impact factor: 17.367

4.  Reflex regulation of arterial pressure during sleep in man. A quantitative method of assessing baroreflex sensitivity.

Authors:  H S Smyth; P Sleight; G W Pickering
Journal:  Circ Res       Date:  1969-01       Impact factor: 17.367

5.  Rapid resetting of the aortic baroreceptors in the rabbit and its implications for short-term and longer term reflex control.

Authors:  P K Dorward; M C Andresen; S L Burke; J R Oliver; P I Korner
Journal:  Circ Res       Date:  1982-03       Impact factor: 17.367

6.  Baroreflex sensitivity during the development of spontaneous hypertension in rats.

Authors:  H A Struyker-Boudier; R T Evenwel; J F Smits; H Van Essen
Journal:  Clin Sci (Lond)       Date:  1982-06       Impact factor: 6.124

Review 7.  Calcium-entry blockers and vascular smooth muscle.

Authors:  P M Vanhoutte
Journal:  Circulation       Date:  1982-01       Impact factor: 29.690

8.  Short-term effects of felodipine, a new dihydropyridine, in hypertension.

Authors:  O Andersson; C Bengtsson; D Elmfeldt; K Haglund; T Hedner; P Seideman; K H Sjöberg; E Strömgren; H Aberg; J Ostman
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

9.  Structural adaptation of the rat left ventricle in response to changes in pressure and volume loads.

Authors:  P Friberg; B Folkow; M Nordlander
Journal:  Acta Physiol Scand       Date:  1985-09

10.  Haemodynamic effects of a new vasodilator drug, felodipine, in healthy subjects.

Authors:  G Johnsson; G Murray; A Tweddel; I Hutton
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more
  16 in total

1.  Treatment of essential hypertension with felodipine in combination with a diuretic.

Authors:  T Hedner; O Samuelsson; E Sjögren; D Elmfeldt
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

2.  The effect of 8 weeks treatment with the calcium antagonist felodipine on blood pressure, heart rate, working capacity, plasma renin activity, plasma angiotensin II, urinary catecholamines and aldosterone in patients with essential hypertension.

Authors:  P L Katzman; U L Hulthén; B Hökfelt
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335

3.  Short and long term treatment of essential hypertension with felodipine as monotherapy.

Authors:  K Harrington; P Fitzgerald; P O'Donnell; K W Hill; E O'Brien; K O'Malley
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Baroreflex control of renin release in spontaneously hypertensive rats after administration of felodipine.

Authors:  M Nordlander; R Horton; P Thalén
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 5.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

Review 6.  Pharmacodynamic properties of felodipine.

Authors:  B Ljung; M Nordlander
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Effects of felodipine and metoprolol on blood pressure, plasma renin, angiotensin II, aldosterone and catecholamines in hypertensive patients.

Authors:  P Lijnen; R Fagard; J Staessen; E Moerman; A De Schaepdryver; A Amery
Journal:  Drugs       Date:  1987       Impact factor: 9.546

8.  Attenuation of renal ischaemic injury by felodipine.

Authors:  P G Thalén; M I Nordlander; M E Sohtell; L E Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-04       Impact factor: 3.000

9.  Pharmacokinetics of felodipine in patients with liver disease.

Authors:  C G Regårdh; B Edgar; R Olsson; M Kendall; P Collste; C Shansky
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

10.  Vascular selectivity of felodipine.

Authors:  B Ljung
Journal:  Drugs       Date:  1985       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.